Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients [NA]

View source ↗

Summary

A recruiting study evaluating the effects of ProLife 10 FORTE on gut microbiota composition in patients with Ulcerative Colitis in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProLife 10 FORTE

Snippet

Sponsor: University of Padova | Conditions: Ulcerative Colitis in Remission | NA | Status: RECRUITING